BCTG Acquisition Corp.
BCTG
NASDAQ Global Select10.20
USD
- -
- -
CIK
0001819133
ISIN
US05492W1036
CUSIP
05492W103
Return %
Stock
S&P500
1Y
- -
18.21
3Y
- -
64.38
5Y
- -
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Aaron I. Davis
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 11682 El Camino Real San Diego CA United States of America
- IPO Date
- Sep 3, 2020
- CIK
- 0001819133
- Similar Companies
- Business
- BCTG Acquisition Corp. (Nasdaq: BCTG) is a blank-check special purpose acquisition company sponsored by Boxer Capital, LLC, formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily in the biotechnology sector with a focus on targeted oncology opportunities in North America and Europe. The company does not have significant independent operations or products but maintains a trust account holding proceeds from its initial public offering for deployment in an initial business combination; as of recent filings, it holds cash equivalents and marketable securities to support such transactions. Incorporated in 2020 and headquartered in San Diego, California, BCTG Acquisition Corp. went public in September 2020, raising approximately $167 million in gross proceeds priced at $10 per share. In April 2021, it announced a definitive merger agreement with Tango Therapeutics, a clinical-stage biotechnology company developing precision cancer medicines targeting tumor suppressor gene loss; the transaction, which included a $186 million PIPE financing led by Boxer Capital and others, closed in August 2021, resulting in the combined entity trading under the ticker TNGX with Tango Therapeutics as the surviving business, though legacy references to BCTG persist in certain trading contexts. No material developments, such as new funding rounds, acquisitions, or strategic shifts, have been reported for BCTG Acquisition Corp. as a standalone entity since the merger completion over four years ago.
U.S. IPO Weekly Recap: The September IPO Market Kicks Off With A Quiet Week